About Rezolute (RZLT)
Rezolute, Inc. is a clinical-stage biopharmaceutical company, which is developing therapies for metabolic diseases related to chronic glucose imbalance. The Company’s lead clinical asset, RZ358, is in late-stage development for the treatment of conge... Read more
- USD3.84
- USD3.92
- USD3.64
- USD6.19
- 33.20%
- --
- 1.65M
- 313M
- 2.22
- 48.10%
Stock News
7 hours ago
Trump to ease impact of tariffs on U.S. automakers, Lutnick says
MarketWatch
yesterday
Continued job growth could help ward off a recession, Jim Cramer says
CNBC
yesterday
Cramer becomes increasingly bullish on Boeing after adding the stock to the Bullpen
CNBC
yesterday
Are the storm clouds finally starting to part for portfolio stock Apple?
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
